Navigation Links
Statins For Erectile Dysfunction- An Alternative To Viagra?

Men with erectile dysfunction, who do not show improvement with Viagra could now benefit from statin therapy. The preliminary results of a study highlight the use of statins for management of endothelial dysfunction // in patients suffering from erectile dysfunction. The result of this small, yet promising study conducted by University of Pennsylvania researchers is published in the Journal of Sexual Medicine.

Erectile dysfunction (ED) in men more commonly signifies an underlying vascular abnormality involving the lining of the blood vessels. It can lead to build up of plaque and result in blockage of the arteries. The ability to sustain an erection is largely dependent on an adequate blood flow to the penis. Atherosclerosis, a consequence of plaque build up in the penile arteries, often results in ED.

Previous studies have already established an association between heart disease and erectile dysfunction. Both the conditions share similar risk factors. Infact, ED can be a marker for the presence of heart disease.

Nitric oxide is essential for a normal erection, but when the body does not make enough of it, due to vascular disease, erectile dysfunction manifests. Viagra, which is most commonly used for treatment of ED, prevents the break down of nitric acid, ensuring that adequate amount of the compound is left for erection to occur.

The problem with the use of Viagra, however is that about 10-30% of all ED patients, fail to respond to Viagra and are classified as ‘Viagra non-responders’. The researchers identified this small group of men and encouraged them to participate in a double blind, randomized, placebo-controlled clinical trial. The study participants were either given a placebo or Lipitor (high-dose).

Surprisingly, the researchers observed an improvement in the performance of patients who were provided with Lipitor. In order to substantiate the findings, the researchers provided Viagra and document ed the ED treatment outcome. The researchers argue that more nitric oxide could be made available by use of statins that could make the endothelium healthy. Perhaps, it may be possible for the patient to respond better to Viagra at a later stage, owing to enhanced endothelial function.

The results of the present study has valuable clinical implications as it can be used for the management of Type 1 and Type 2 diabetic patients, who suffer from vascular complications. The researchers have warned that more clinical trials involving a large group of patients is necessary before it can be approved for clinical use. Furthermore, factors other than that listed above may be responsible for poor response to Viagra.


'"/>




Related medicine news :

1. Statins reduce heart attacks
2. Statins reduce risks for angioplasty patients
3. Statins Found To Be Helpful For Patients With Arthritis
4. Long-Term Benefits Of Statins Questioned
5. Statins Not Effective In Treating Calcific Aortic Stenosis
6. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
7. The Effects of Statins Questioned
8. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
9. Study Finds No Link Between Statins And Breast Cancer Risk
10. Statins Reduce Deaths And Strokes After Carotid Surgery
11. Statins reduces cardiovascular risk but no cancer risk.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/29/2017)... , ... March 29, 2017 , ... VisualSP has helped ... Until recently, the only option for on-premises installation of its Help System for SharePoint ... to install the system into the entire tenant. , The company recently released ...
(Date:3/28/2017)... ... 28, 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes ... Risk Test to find out if they are at risk for developing Type 2 ... the evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies announced ... address the resolution to globally reduce the harmful use of alcohol set forth ... and TTB approved ingredients that when infused into alcohol, renders the alcohol liver ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global energy-based aesthetic devices market to grow at ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:3/29/2017)... , March 29, 2017  Novartis announced ... (FDA) has accepted the company,s Biologics License Application ... (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell ... and young adult patients with B-cell acute lymphoblastic ... by Novartis for a CAR-T. The priority review ...
(Date:3/29/2017)...  The Global Health Innovative Technology Fund (GHIT ... battle infectious diseases around the globe, today announced ... help deliver a range of new innovative therapies ... This latest round of targeted support includes ... a pediatric formulation of a drug considered the ...
Breaking Medicine Technology: